These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 28818009)

  • 1. Transparency of Biobank Access in Canada: An Assessment of Industry Access and the Availability of Information on Access Policies and Resulting Research.
    Gibson SG; Axler RE; Lemmens T
    J Empir Res Hum Res Ethics; 2017 Dec; 12(5):310-325. PubMed ID: 28818009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding public reactions to commercialization of biobanks and use of biobank resources.
    Nicol D; Critchley C; McWhirter R; Whitton T
    Soc Sci Med; 2016 Aug; 162():79-87. PubMed ID: 27343817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transparency About Governance Contributes to Biobanks' Trustworthiness: Call for Action.
    Gille F; Axler R; Blasimme A
    Biopreserv Biobank; 2021 Feb; 19(1):83-85. PubMed ID: 33124891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "It's all about trust": reflections of researchers on the complexity and controversy surrounding biobanking in South Africa.
    Moodley K; Singh S
    BMC Med Ethics; 2016 Oct; 17(1):57. PubMed ID: 27724893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative study on custodianship of human biological material and data stored in biobanks.
    Verlinden M; Nys H; Ectors N; Huys I
    BMC Med Ethics; 2016 Mar; 17():15. PubMed ID: 26926004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Getting a Fair Share: Attitudes and Perceptions of Biobank Stakeholders Concerning the Fairness of Sample Sharing.
    Colledge F; Elger B
    Bioethics; 2015 Jul; 29(6):424-30. PubMed ID: 25425240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of commercialisation and genetic data sharing arrangements on public trust and the intention to participate in biobank research.
    Critchley C; Nicol D; Otlowski M
    Public Health Genomics; 2015; 18(3):160-72. PubMed ID: 25790760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Market-driven production of biospecimens and the role of NHS hospital-led biobanks.
    Timmons S; Vezyridis P
    Sociol Health Illn; 2017 Sep; 39(7):1242-1257. PubMed ID: 28555937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balancing the local and the universal in maintaining ethical access to a genomics biobank.
    Heeney C; Kerr SM
    BMC Med Ethics; 2017 Dec; 18(1):80. PubMed ID: 29282045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access Governance for Biobanks: The Case of the BioSHaRE-EU Cohorts.
    Kaye J; Briceño Moraia L; Mitchell C; Bell J; Bovenberg JA; Tassé AM; Knoppers BM
    Biopreserv Biobank; 2016 Jun; 14(3):201-6. PubMed ID: 27183185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and progress of Ireland's biobank network: Ethical, legal, and social implications (ELSI), standardized documentation, sample and data release, and international perspective.
    Mee B; Gaffney E; Glynn SA; Donatello S; Carroll P; Connolly E; Garrigle SM; Boyle T; Flannery D; Sullivan FJ; McCormick P; Griffin M; Muldoon C; Fay J; O'Grady T; Kay E; Eustace J; Burke L; Sheikh AA; Finn S; Flavin R; Giles FJ
    Biopreserv Biobank; 2013 Feb; 11(1):3-11. PubMed ID: 24845249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future-proofing biobanks' governance.
    Gille F; Vayena E; Blasimme A
    Eur J Hum Genet; 2020 Aug; 28(8):989-996. PubMed ID: 32424324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biobanks and the Moral Concerns of Donors: A Democratic Deliberation.
    De Vries RG; Ryan KA; Gordon L; Krenz CD; Tomlinson T; Jewell S; Kim SYH
    Qual Health Res; 2019 Nov; 29(13):1942-1953. PubMed ID: 30095038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Access arrangements' for biobanks: a fine line between facilitating and hindering collaboration.
    Fortin S; Pathmasiri S; Grintuch R; Deschênes M
    Public Health Genomics; 2011; 14(2):104-14. PubMed ID: 20689244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Position Statement from the German Biobank Alliance on the Cooperation Between Academic Biobanks and Industry Partners.
    Baber R; Hummel M; Jahns R; von Jagwitz-Biegnitz M; Kirsten R; Klingler C; Nussbeck SY; Specht C
    Biopreserv Biobank; 2019 Aug; 17(4):372-374. PubMed ID: 31314575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Business Planning for a Campus-Wide Biobank.
    Tarling TE; Lasser F; Carter C; Matzke LA; Dhugga G; Arora N; Dee S; LeBlanc J; Babinsky S; O'Donoghue S; Cheah S; Watson P; Vercauteren SM
    Biopreserv Biobank; 2017 Feb; 15(1):37-45. PubMed ID: 28151006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proposed approach to informed consent for biobanks in China.
    Liu M; Hu Q
    Bioethics; 2014 May; 28(4):181-6. PubMed ID: 22762502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commercial biobanks and genetic research: ethical and legal issues.
    Anderlik M
    Am J Pharmacogenomics; 2003; 3(3):203-15. PubMed ID: 12814328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access policies in biobank research: what criteria do they include and how publicly available are they? A cross-sectional study.
    Langhof H; Kahrass H; Sievers S; Strech D
    Eur J Hum Genet; 2017 Feb; 25(3):293-300. PubMed ID: 28000694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biobanks in the low- and middle-income countries of the Arab Middle East region: challenges, ethical issues, and governance arrangements-a qualitative study involving biobank managers.
    Abdelhafiz AS; Ahram M; Ibrahim ME; Elgamri A; Gamel E; Labib R; Silverman H
    BMC Med Ethics; 2022 Aug; 23(1):83. PubMed ID: 35965314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.